tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
AstraZeneca PLC (GB:AZN)
LSE:AZN
AZN
AstraZeneca
Stock Analysis
Analyst Forecasts
News & Insights
Technical Analysis
Chart
Earnings
Dividends
Ownership
Financials
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Holding GB:AZN?
Track your performance easily
Link Broker

AstraZeneca (AZN) Stock News & Sentiment

538 Followers
Levi & Korsinsky LLP Announces the Filing of a Securities Class Action on Behalf of AstraZeneca PLC(AZN) Shareholders
Premium
Class Action
Levi & Korsinsky LLP Announces the Filing of a Securities Class Action on Behalf of AstraZeneca PLC(AZN) Shareholders
4d ago
AZN
AstraZeneca Withdraws EU Application for Lung Cancer Drug
Premium
Company Announcements
AstraZeneca Withdraws EU Application for Lung Cancer Drug
7d ago
AstraZeneca’s Tagrisso Gains EU Approval for Unresectable EGFR-Mutated Lung Cancer
Premium
Company Announcements
AstraZeneca’s Tagrisso Gains EU Approval for Unresectable EGFR-Mutated Lung Cancer
8d ago
AstraZeneca Strengthens Board with New Non-Executive Director Appointments
Premium
Company Announcements
AstraZeneca Strengthens Board with New Non-Executive Director Appointments
15d ago
AstraZeneca’s Imfinzi Approved for Lung Cancer Treatment
Premium
Company Announcements
AstraZeneca’s Imfinzi Approved for Lung Cancer Treatment
26d ago
AstraZeneca Strengthens Leadership with New EVP Appointment
Premium
Company Announcements
AstraZeneca Strengthens Leadership with New EVP Appointment
27d ago
AstraZeneca Announces Share Capital and Voting Rights
Premium
Company Announcements
AstraZeneca Announces Share Capital and Voting Rights
29d ago
More GB:AZN News >

AZN News on the Web

London stocks close mixed in quiet post-Christmas trade
ShareCast
Neutral
European markets higher in shortened session ahead of Christmas; Novo Nordisk resumes recovery
CNBC
Neutral
AstraZeneca’s Tagrisso gains EC approval for NSCLC treatment
Pharmaceutical Technology
Neutral
AstraZeneca pulls lung cancer drug application in EU
Proactive Investors
Neutral
FTSE 100 Live: Stocks higher; EV targets reviewed; Vistry warns on profit
Proactive Investors
Neutral
AstraZenca's Tagrisso approved in Europe for rare lung cancer
Proactive Investors
Neutral
If the market shut down for 10 years, I’d be happy to hold these 2 FTSE 100 shares
Fool.co.uk
Neutral
Merck-AstraZeneca breast cancer drug reduces risk of death by 28% in patients diagnosed early, clinical trial shows
Fortune
Neutral

News Score - Last 7 Days

Neutral
GB:AZN
Sector Average
Media Buzz
This Week1 articles
Weekly Average5.75 articles
News Sentiment
This Week50%
Sector Average66%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GB:AZN’s Media Buzz Sentiment?
1 articles about GB:AZN were published this week. In an average week, 5.75 articles are published.
    What is GB:AZN’s weekly average amount of articles?
    In an average week, 5.75 articles about GB:AZN are published.
      What is GB:AZN’s News Sentiment?
      50% of articles about GB:AZN were positive this week, compared to its sector average of 66%.
        Healthcare Stocks that are Trending in the News
        IDYAIDEAYA Biosciences
        SGMOSangamo Biosciences
        AXSMAxsome Therapeutics
        LEGNLegend Biotech
        IMEImExHS Limited
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing